Regatta Capital Group Boosts Investment in Lam Research Co.

Regatta Capital Group LLC has significantly increased its stake in Lam Research Co. (NASDAQ:LRCX - Free Report), raising its holdings by an impressive 882.0% during the fourth quarter. This information was disclosed in the firm's recent filing with the Securities and Exchange Commission (SEC). Following this surge, the fund now owns a total of 8,141 shares of Lam Research's stock after acquiring an additional 7,312 shares during the quarter. As of the latest filing, Regatta Capital Group's investment in Lam Research is valued at approximately $588,000.

Other institutional investors have also made changes to their positions in Lam Research. For instance, Parisi Gray Wealth Management increased its holdings in the company by 652.9% during the fourth quarter, bringing its total to 8,350 shares worth around $603,000 after adding 7,241 shares. Additionally, Burns J W & Co. Inc. NY established a new position in Lam Research, with its stake amounting to approximately $815,000. Jennison Associates LLC saw an increase in its shares by 20.0% in the third quarter, now holding 238,275 shares valued at $194,451,000, which includes a purchase of an additional 39,725 shares last quarter. Other funds, like Creative Planning and Vest Financial LLC, also grew their stakes in the company.

Overview of Lam Research's Market Performance

As of Friday, the shares of Lam Research Co. (NASDAQ:LRCX) opened at $79.68. The company boasts a market capitalization of $102.52 billion and has a P/E ratio of 25.75, alongside a price-to-earnings-growth (PEG) ratio of 1.53. The beta for the stock is 1.45, indicating its volatility compared to the market. The stock’s fifty-day moving average stands at $75.43, while the two-hundred day moving average is $80.07. Lam Research recorded a 12-month low of $68.87 and a high of $113.00.

Recent Earnings Report and Financials

Lam Research recently reported its quarterly earnings on Wednesday, October 23rd. The semiconductor company announced earnings per share (EPS) of $0.86 for the quarter, surpassing analysts' expectations of $0.81 by $0.05. The company demonstrated a strong net margin of 26.02% and a return on equity of 50.60%. In terms of revenue, Lam Research generated $4.17 billion, exceeding the consensus estimate of $4.06 billion. This reflects a 19.7% increase in revenue year-over-year, compared to $6.85 EPS posted from the same period last year. Analysts predict that Lam Research will report 3.51 EPS for the current fiscal year.

Dividend Announcement

Moreover, Lam Research has also announced a quarterly dividend that was paid to investors on Wednesday, January 8th. The dividend of $0.23 per share was given to shareholders who were on record as of Wednesday, December 11th, which carries an annualized dividend of $0.92, reflecting a 1.15% yield. The company's dividend payout ratio stands at 29.74%.

Analyst Ratings and Future Outlook

Various research analysts have issued opinions on Lam Research shares. KeyCorp has increased its rating from "sector weight" to "overweight," setting a target price of $95.00 in a report dated January 17th. Wolfe Research downgraded Lam Research from "outperform" to "peer perform" on January 15th. Needham & Company LLC reaffirmed a "buy" rating with a target price of $100.00 on October 24th. Additionally, StockNews.com changed its rating from "buy" to "hold" on October 11th, while Stifel Nicolaus also reaffirmed a "buy" rating with a revised target price of $100.00. According to MarketBeat, Lam Research has received a consensus rating of "Moderate Buy" from nine analysts, while fourteen analysts recommend a buy, with the average target price set at $95.77.

Company Profile of Lam Research

Lam Research Corporation specializes in the design, manufacture, marketing, refurbishment, and servicing of semiconductor processing equipment used for integrated circuit fabrication. The product offerings include ALTUS systems for tungsten metallization, SABRE products for copper interconnect transitions, SOLA products for film treatments, and VECTOR plasma-enhanced CVD ALD products.

investment, stocks, semiconductors